BCL6 and ovarian carcinoma: Therefore, it is speculated that tumors can be synergistically inhibited by combining BCL6 inhibitors with chemotherapy drugs, which may provide some treatment options for patients with drug-resistant ovarian cancer or patients who are insensitive to chemotherapy drugs.